142 related articles for article (PubMed ID: 20388135)
1. Phytanic acid--an overlooked bioactive fatty acid in dairy fat?
Hellgren LI
Ann N Y Acad Sci; 2010 Mar; 1190():42-9. PubMed ID: 20388135
[TBL] [Abstract][Full Text] [Related]
2. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
Mobley JA; Leav I; Zielie P; Wotkowitz C; Evans J; Lam YW; L'Esperance BS; Jiang Z; Ho SM
Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):775-83. PubMed ID: 12917210
[TBL] [Abstract][Full Text] [Related]
3. Dietary influences on tissue concentrations of phytanic acid and AMACR expression in the benign human prostate.
Kataria Y; Wright M; Deaton RJ; Rueter EE; Rybicki BA; Moser AB; Ananthanrayanan V; Gann PH
Prostate; 2015 Feb; 75(2):200-10. PubMed ID: 25307752
[TBL] [Abstract][Full Text] [Related]
4. Stereochemistry of the peroxisomal branched-chain fatty acid alpha- and beta-oxidation systems in patients suffering from different peroxisomal disorders.
Ferdinandusse S; Rusch H; van Lint AE; Dacremont G; Wanders RJ; Vreken P
J Lipid Res; 2002 Mar; 43(3):438-44. PubMed ID: 11893780
[TBL] [Abstract][Full Text] [Related]
5. Phytanic acid, a novel activator of uncoupling protein-1 gene transcription and brown adipocyte differentiation.
Schlüter A; Barberá MJ; Iglesias R; Giralt M; Villarroya F
Biochem J; 2002 Feb; 362(Pt 1):61-9. PubMed ID: 11829740
[TBL] [Abstract][Full Text] [Related]
6. AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.
Wright JL; Neuhouser ML; Lin DW; Kwon EM; Feng Z; Ostrander EA; Stanford JL
Prostate; 2011 Apr; 71(5):498-506. PubMed ID: 20945498
[TBL] [Abstract][Full Text] [Related]
7. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
Kruska N; Reiser G
Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
[TBL] [Abstract][Full Text] [Related]
8. Serum phytanic and pristanic acid levels and prostate cancer risk in Finnish smokers.
Wright ME; Albanes D; Moser AB; Weinstein SJ; Snyder K; Männistö S; Gann PH
Cancer Med; 2014 Dec; 3(6):1562-9. PubMed ID: 25132681
[TBL] [Abstract][Full Text] [Related]
9. Phytanic acid: measurement of plasma concentrations by gas-liquid chromatography-mass spectrometry analysis and associations with diet and other plasma fatty acids.
Allen NE; Grace PB; Ginn A; Travis RC; Roddam AW; Appleby PN; Key T
Br J Nutr; 2008 Mar; 99(3):653-9. PubMed ID: 17868488
[TBL] [Abstract][Full Text] [Related]
10. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Zomer AW; van Der Burg B; Jansen GA; Wanders RJ; Poll-The BT; van Der Saag PT
J Lipid Res; 2000 Nov; 41(11):1801-7. PubMed ID: 11060349
[TBL] [Abstract][Full Text] [Related]
11. Phytanic acid, but not pristanic acid, mediates the positive effects of phytol derivatives on brown adipocyte differentiation.
Schluter A; Giralt M; Iglesias R; Villarroya F
FEBS Lett; 2002 Apr; 517(1-3):83-6. PubMed ID: 12062414
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
Elmazar MM; Nau H
Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
[TBL] [Abstract][Full Text] [Related]
13. Phytol-induced hepatotoxicity in mice.
Mackie JT; Atshaves BP; Payne HR; McIntosh AL; Schroeder F; Kier AB
Toxicol Pathol; 2009 Feb; 37(2):201-8. PubMed ID: 19188468
[TBL] [Abstract][Full Text] [Related]
14. Phytol and its metabolites phytanic and pristanic acids for risk of cancer: current evidence and future directions.
Bobe G; Zhang Z; Kopp R; Garzotto M; Shannon J; Takata Y
Eur J Cancer Prev; 2020 Mar; 29(2):191-200. PubMed ID: 31436750
[TBL] [Abstract][Full Text] [Related]
15. Phytanic acid is a retinoid X receptor ligand.
Lemotte PK; Keidel S; Apfel CM
Eur J Biochem; 1996 Feb; 236(1):328-33. PubMed ID: 8617282
[TBL] [Abstract][Full Text] [Related]
16. The metabolism of phytanic acid and pristanic acid in man: a review.
Verhoeven NM; Wanders RJ; Poll-The BT; Saudubray JM; Jakobs C
J Inherit Metab Dis; 1998 Oct; 21(7):697-728. PubMed ID: 9819701
[TBL] [Abstract][Full Text] [Related]
17. Phytanic acid, AMACR and prostate cancer risk.
Thornburg T; Turner AR; Chen YQ; Vitolins M; Chang B; Xu J
Future Oncol; 2006 Apr; 2(2):213-23. PubMed ID: 16563090
[TBL] [Abstract][Full Text] [Related]
18. Human metabolism of phytanic acid and pristanic acid.
Verhoeven NM; Jakobs C
Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
[TBL] [Abstract][Full Text] [Related]
19. Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR.
Kitareewan S; Burka LT; Tomer KB; Parker CE; Deterding LJ; Stevens RD; Forman BM; Mais DE; Heyman RA; McMorris T; Weinberger C
Mol Biol Cell; 1996 Aug; 7(8):1153-66. PubMed ID: 8856661
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of phytanic acid are associated with prostate cancer risk.
Xu J; Thornburg T; Turner AR; Vitolins M; Case D; Shadle J; Hinson L; Sun J; Liu W; Chang B; Adams TS; Zheng SL; Torti FM
Prostate; 2005 May; 63(3):209-14. PubMed ID: 15712232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
